Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Public ClinicalTrials.gov record NCT06927739. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Orticumab in Participants With Prior Myocardial Infarction Who Have Elevated Coronary Inflammation Based on FAI Score Assessed by CCTA
Study identification
- NCT ID
- NCT06927739
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Abcentra
- Industry
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Interventions
- Orticumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 10, 2025
- Primary completion
- Feb 7, 2027
- Completion
- May 31, 2027
- Last update posted
- Jan 26, 2026
2025 – 2027
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Abcentra Investigational Site | Los Angeles | California | 90048 | Not yet recruiting |
| Abcentra Investigational Site | Torrance | California | 90502 | Recruiting |
| Abcentra Investigational Site | Boca Raton | Florida | 33434 | Recruiting |
| Abcentra Investigational Site | Richmond | Indiana | 47374 | Recruiting |
| Abcentra Investigational Site | Louisville | Kentucky | 40202 | Not yet recruiting |
| Abcentra Investigational Site | Baltimore | Maryland | 21215 | Recruiting |
| Abcentra Investigational Site | Midland | Michigan | 48670 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06927739, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06927739 live on ClinicalTrials.gov.